SlideShare a Scribd company logo
1 of 12
Download to read offline
Schedule ‘M’
DETAILED STUDY
Rahul Pal
B. Pharm (5th Sem)
Schedule “M”
“Goods Manufacturing Practices (GMP)” are minimum standards used in the
manufacturing process that assure that the product meets requirements of safety, identity,
strength, quality, and purity.
 The FDA attempts to inspect manufacturers every 2 years.
 The Schedule M has again been amended in a major way by the Drugs and Cosmetics (8th
Amendment) Rules, 2001 w.e.f. 11th December 2001.
 These rules shall not apply to the manufacturers who are presently licensed to
manufacture drugs for the period up to the 31st Dec. 2003.
 The manufacturing premises shall be used exclusively for production of drugs and not for
any other manufacturing.
• It is defined as “the part of quality assurance which is aimed to ensure that the product is
consistently manufactured to the quality appropriate to their intended use”.
• It prescribes the requirements of premises, plant and equipment needed for setting up
manufacturing unit.
Part: 01. Requirements for Premises & Materials:
Part: 02.
Requirements for
Plant & Equipments:
 Area.
 Equipments.
Parts of
Schedule “M”:
 Part 1.
 Part 1A.
 Part 1B.
 Part 1C.
 Part 1D.
 Part 1E.
1) Location & surrounding.
2) Buildings & Premises.
3) Water Supply.
4) Disposable of Waste.
5) Storage.
6) Working Space.
7) Sterile Products.
8) Container’s Cleaning.
9) Machinery.
10) Raw materials.
11) Equipments.
12) Batch manufacturing Record.
13) Health Clothing, Sanitation &
Hygiene of Workers.
14) Medical Services.
15) Distribution Record.
16) Record of Marketing Complaints.
17) Quality Control.
Part-1: Requirements for Premises and
Materials
01). Locations and Surroundings*: The factory building shall be situated and
constructed to avoid contamination from sewerage, drain, disagreeable, dust and smoke etc.
02). Buildings and Premises*:
Manufacturing shall permit work under hygienic conditions. It should be free from any insects.
Light and ventilation facility should be adequate. Walls and floor should be free from cracks
and damp. It shall be located so as to be:
a) The flooring shall be smooth.
b) Building should have a proper drainage system.
c) Proper fire safety measures and proper exists should be there.
• Drying space for raw material, in process medicines should be separate and measures
should be done to prevent it from flies/insects/dust etc.
03. Water Supply*: Water supply should be pure and of potable quality. Adequate
provision of water for wasting the premises shall be made.
04. Disposable of Waste*:
(i) Disposal of sewage and effluents from the factory should be as per “Environment
Pollution Control Board’’.
(ii) All bio-medical wastes should be destroyed as per “Biomedical Waste
management rules-1996”.
05. Stores*: Store should have adequate space for independently and separately
store raw material, packaging material and finished products.
06. Working Space*: Manufacturing area should be adequate for orderly
placement of equipment, machinery and material used during manufacturing
operations and quality control to facilitate easy and safe working.
07. Sterile Products*: Sterile products separate enclosed areas shall be provided
with the air lock system for the entry and shall be essentially dust free and has to be
carried out.
• Air supply shall be filtered through bacteria proof filter (HEPA filter). Access to
manufacturing area shall be restricted to minimum number of authorized personal.
• Special procedure to be followed for entering and leaving the manufacturing area
shall be written down and displayed.
08. Container’s Cleaning*: Washing, cleaning and drying section of
containers such as bottles and jars should have adequate arrangement.
09. Machinery*: To carry out manufacturing process, adequate machinery and
equipment require. These machineries could be manually operated or semi-
automatic or fully automatic based upon your need and investment.
10. Raw-Materials*: The licensee shall keep on inventory of all raw material to be
used at any stage of manufacture of drugs and maintain the record as per schedule U. All
such raw material be:
(a) Identified and their container examined for damage and assigned control number.
(b) Stored at optimum temperature and relative humidity.
(c) Systematically sampled by quality control personnel.
(d) Tested for compliance with required standard of quality.
• The stock rotation is so organized that, it is on the basis of first come first out.
11. Equipment*: Equipment used for the manufacturing shall be constructed
designed, installed and maintained to:
a. Achieve operational efficiency to attain desired quality.
b. Minimize any contamination of drug and their container during manufacture.
• Equipment used for critical steps in progress shall be maintained by device capable of
recording the parameter or withdrawn systems to indicate malfunction.
12. Batch Manufacturing Record*:
Batch record should be maintained irrespective of product manufactured:
• Manufacturing records are required to provide the list of raw materials and their
quantities obtained from the store, tests conducted during the various stages of
manufacture like taste, colour, physical characteristics and chemical tests.
 Manufacturing Batch record should be signed by production chemist and analytical
chemist.
• Only after the manufactured drugs have been verified and accepted quality shall be
allowed to be cleared for sale.
13. Health Clothing, Sanitation and Hygiene of Workers*:
All workers should be healthy and should be free from contagious diseases.
 Proper uniform should be provided to workers according to nature of work.
 A uniform may include cloth or synthetic covering for hands, feet and head wherever
required.
 Adequate facilities for personal use provided like clean towel, soap etc.
 Lavatories for men and women should be separate and should be away from
processing and manufacturing area.
• Changing room facility should also be provided for changing their clothes.
14. Medical Services*: Adequate facility for first aids should be provided by
manufacturer.
Medical examination of workers at the time of employment and periodical check-up
should be conducted at least once in a year and proper record should be maintained.
15. Distribution Record*: Distribution record (Dispatch register) should be
maintained to facilitate process of prompt and complete recall of the batch. Distribution
record should be maintained till expiry of batch.
16. Record of Market Complaints*: A register should maintain to record all
reports of market complaints received regarding the products sold in the market.
• The manufacturer shall enter all data received on such market complaints;
investigations carried out by the manufacturers regarding the complaint & shall also be
recorded.
• “Once in a period of six months the manufacturer shall submit the record of such
complaints to the licensing authority.”
• Reports of any adverse reaction resulting from the use of drugs maintained in a
separate register by manufacturer.
17. Quality Control*: A manufacturer can set-up own quality control section or testing
could be done through government approved testing laboratory.
Part-2: Requirements for Plant and
Equipments
01. Area:
a) Basic Installation - Requires minimum of 30 sq. mt. (for tablets manufacturing, up
to 60 sq. mt.)
b) Ancillary Area: 10 sq. mt. (for tablets manufacturing, up to 20 sq. mt.)
02. Equipment:
Colloidal mill, mixing and storage tanks, stainless steel containers, Planetary mixer, Triple
roller, tube filling equipments, filter proof cap sealing machine, water distillation unit,
clarity testing inspection unit, disintegrator and sifter, granulator, tray or fluidized bed
driers, weighing machine, tablet compression machine, tablet inspection unit,
dissolution test apparatus, hardness tester, friability tester, disintegration test
apparatus, air conditioners, polishing pan, jacketed kettle, leakage test apparatus, capsule
filling unit, hot air ovens, Laminar air flow unit, bottle washing machines, autoclave,
transfer pumps, trimming machine, cutting machine etc.
Parts of Schedule ‘M’
• Part 1: Describes Good Manufacturing Practices for Premises and Material.
• Part 1A: Describes the specific requirement for manufacture of sterile products.
Parenteral preparations and Sterile Ophthalmic Preparations.
• Part 1B: Describes the specific requirements for manufacture of oral solid
forms (Capsule and Tablets)
• Part 1C: Describes the specific requirements for manufacture of oral liquids
(syrups, elixirs, emulsions and suspensions).
• Part 1D: Describes the specific requirements for manufacture of topical
products i.e. External Preparations (Cream, Ointments, Pastes, Emulsions,
Lotions, Solutions)
• Part 1E: Describes the specific requirements for manufacture of Metered Dose
Inhalers (MDI). The other associated codes such as those of Good laboratory
practice (GLP) and Good clinical practice (GCP).
THANKU!

More Related Content

What's hot

Qualification of UV VISIBLE SPECTROPHOTOMETER
Qualification of UV VISIBLE SPECTROPHOTOMETERQualification of UV VISIBLE SPECTROPHOTOMETER
Qualification of UV VISIBLE SPECTROPHOTOMETERDr.K.Venkateswara raju
 
Pharmaceutical validation, calibration & qualifications
Pharmaceutical validation, calibration & qualificationsPharmaceutical validation, calibration & qualifications
Pharmaceutical validation, calibration & qualificationsSuraj Ghorpade
 
Ich guidelines for stability studies 1
Ich guidelines for stability studies 1Ich guidelines for stability studies 1
Ich guidelines for stability studies 1priyanka odela
 
Manufacturing operation and control
Manufacturing operation and controlManufacturing operation and control
Manufacturing operation and controlMalay Pandya
 
Quality risk management -Technology development and transfer
Quality risk management -Technology  development and transferQuality risk management -Technology  development and transfer
Quality risk management -Technology development and transfersneha_pharmacist
 
Unit 4 Document maintenance in Pharmaceutical Industry.pptx
Unit 4 Document maintenance in Pharmaceutical Industry.pptxUnit 4 Document maintenance in Pharmaceutical Industry.pptx
Unit 4 Document maintenance in Pharmaceutical Industry.pptxAshwiniBhoir2
 
Equipments and Raw Materials
Equipments and Raw MaterialsEquipments and Raw Materials
Equipments and Raw MaterialsTeny Thomas
 
Equipments And Raw Material
Equipments And Raw MaterialEquipments And Raw Material
Equipments And Raw Materialsunayanamali
 
Product Complaints and Recall: Quality Assurance
Product Complaints and Recall: Quality Assurance Product Complaints and Recall: Quality Assurance
Product Complaints and Recall: Quality Assurance PRASHANT JADHAV
 
Gmp premises 112070804006
Gmp premises 112070804006Gmp premises 112070804006
Gmp premises 112070804006Patel Parth
 
General Principles of Analytical Method of Validation.pdf
General Principles of Analytical Method of Validation.pdfGeneral Principles of Analytical Method of Validation.pdf
General Principles of Analytical Method of Validation.pdfTamannaKumari8
 
Drug Industry Location & Design.pptx
Drug Industry Location & Design.pptxDrug Industry Location & Design.pptx
Drug Industry Location & Design.pptxMansiChauhan98
 
GOOD LABORATORY PRACTICES - A DETAILED STUDY
GOOD LABORATORY PRACTICES - A DETAILED STUDYGOOD LABORATORY PRACTICES - A DETAILED STUDY
GOOD LABORATORY PRACTICES - A DETAILED STUDYTeny Thomas
 
Analytical method development,validation by uv spectroscopy
Analytical method development,validation by uv spectroscopyAnalytical method development,validation by uv spectroscopy
Analytical method development,validation by uv spectroscopythota lakshmi bhavani
 
Complaints (QUALITY ASSURANCE)
Complaints (QUALITY ASSURANCE)Complaints (QUALITY ASSURANCE)
Complaints (QUALITY ASSURANCE)ShrutiBattinwar
 
Premises - Part of Good Manufacturing Practices
Premises - Part of Good Manufacturing PracticesPremises - Part of Good Manufacturing Practices
Premises - Part of Good Manufacturing PracticesTeny Thomas
 
Environmental Control in Pharma industry
Environmental Control in Pharma industryEnvironmental Control in Pharma industry
Environmental Control in Pharma industryMithilesh Patel
 

What's hot (20)

Qualification of UV VISIBLE SPECTROPHOTOMETER
Qualification of UV VISIBLE SPECTROPHOTOMETERQualification of UV VISIBLE SPECTROPHOTOMETER
Qualification of UV VISIBLE SPECTROPHOTOMETER
 
Pharmaceutical validation, calibration & qualifications
Pharmaceutical validation, calibration & qualificationsPharmaceutical validation, calibration & qualifications
Pharmaceutical validation, calibration & qualifications
 
Ich guidelines for stability studies 1
Ich guidelines for stability studies 1Ich guidelines for stability studies 1
Ich guidelines for stability studies 1
 
Master formula record
Master formula recordMaster formula record
Master formula record
 
Manufacturing operation and control
Manufacturing operation and controlManufacturing operation and control
Manufacturing operation and control
 
Quality risk management -Technology development and transfer
Quality risk management -Technology  development and transferQuality risk management -Technology  development and transfer
Quality risk management -Technology development and transfer
 
Unit 4 Document maintenance in Pharmaceutical Industry.pptx
Unit 4 Document maintenance in Pharmaceutical Industry.pptxUnit 4 Document maintenance in Pharmaceutical Industry.pptx
Unit 4 Document maintenance in Pharmaceutical Industry.pptx
 
Equipments and Raw Materials
Equipments and Raw MaterialsEquipments and Raw Materials
Equipments and Raw Materials
 
Equipments And Raw Material
Equipments And Raw MaterialEquipments And Raw Material
Equipments And Raw Material
 
Ipqc
Ipqc Ipqc
Ipqc
 
Small volume parenterals
Small volume parenteralsSmall volume parenterals
Small volume parenterals
 
Product Complaints and Recall: Quality Assurance
Product Complaints and Recall: Quality Assurance Product Complaints and Recall: Quality Assurance
Product Complaints and Recall: Quality Assurance
 
Gmp premises 112070804006
Gmp premises 112070804006Gmp premises 112070804006
Gmp premises 112070804006
 
General Principles of Analytical Method of Validation.pdf
General Principles of Analytical Method of Validation.pdfGeneral Principles of Analytical Method of Validation.pdf
General Principles of Analytical Method of Validation.pdf
 
Drug Industry Location & Design.pptx
Drug Industry Location & Design.pptxDrug Industry Location & Design.pptx
Drug Industry Location & Design.pptx
 
GOOD LABORATORY PRACTICES - A DETAILED STUDY
GOOD LABORATORY PRACTICES - A DETAILED STUDYGOOD LABORATORY PRACTICES - A DETAILED STUDY
GOOD LABORATORY PRACTICES - A DETAILED STUDY
 
Analytical method development,validation by uv spectroscopy
Analytical method development,validation by uv spectroscopyAnalytical method development,validation by uv spectroscopy
Analytical method development,validation by uv spectroscopy
 
Complaints (QUALITY ASSURANCE)
Complaints (QUALITY ASSURANCE)Complaints (QUALITY ASSURANCE)
Complaints (QUALITY ASSURANCE)
 
Premises - Part of Good Manufacturing Practices
Premises - Part of Good Manufacturing PracticesPremises - Part of Good Manufacturing Practices
Premises - Part of Good Manufacturing Practices
 
Environmental Control in Pharma industry
Environmental Control in Pharma industryEnvironmental Control in Pharma industry
Environmental Control in Pharma industry
 

Similar to Schedule ‘M’ manufacturing standards

Drugs & Cosmetics Act 1940 Part VI
Drugs & Cosmetics Act 1940 Part VIDrugs & Cosmetics Act 1940 Part VI
Drugs & Cosmetics Act 1940 Part VIPranay Sethiya
 
SCHEDULE T GMP INDIAN SYSTEM OF MEDICINE
SCHEDULE T GMP INDIAN SYSTEM OF MEDICINE SCHEDULE T GMP INDIAN SYSTEM OF MEDICINE
SCHEDULE T GMP INDIAN SYSTEM OF MEDICINE Pranjal Saxena
 
Drugs & Cosmetics Act 1940 Part V
Drugs & Cosmetics Act 1940 Part VDrugs & Cosmetics Act 1940 Part V
Drugs & Cosmetics Act 1940 Part VPranay Sethiya
 
Schedule M-Jurisprudence
Schedule M-JurisprudenceSchedule M-Jurisprudence
Schedule M-JurisprudenceSaiyam Agarwal
 
SCHEDULE M,industrial pharmacy 3rd sem.pptx
SCHEDULE M,industrial pharmacy 3rd sem.pptxSCHEDULE M,industrial pharmacy 3rd sem.pptx
SCHEDULE M,industrial pharmacy 3rd sem.pptxnaikanu3813
 
SCHEDULE M, Pharmaceutical Jurisprudence, 5th sem
SCHEDULE M, Pharmaceutical Jurisprudence, 5th semSCHEDULE M, Pharmaceutical Jurisprudence, 5th sem
SCHEDULE M, Pharmaceutical Jurisprudence, 5th semnaikanu3813
 
Schedule T Good Manufacturing Practice Indian systems of Medicine
Schedule T Good Manufacturing Practice Indian systems of MedicineSchedule T Good Manufacturing Practice Indian systems of Medicine
Schedule T Good Manufacturing Practice Indian systems of MedicineDr K SUDHEER KUMAR KANDIBANDA
 
Schedule M- Drugs and cosmetic act 1940 and rules 1945
Schedule M- Drugs and cosmetic act 1940 and rules 1945Schedule M- Drugs and cosmetic act 1940 and rules 1945
Schedule M- Drugs and cosmetic act 1940 and rules 1945Swarna kumari S
 
GMP, Goods manufacturer Practices, Drug and Cosmetic act
GMP, Goods manufacturer Practices, Drug and Cosmetic actGMP, Goods manufacturer Practices, Drug and Cosmetic act
GMP, Goods manufacturer Practices, Drug and Cosmetic actDrSampuranSuahg
 
GMP presentation.pptx
GMP presentation.pptxGMP presentation.pptx
GMP presentation.pptxgarima mailk
 

Similar to Schedule ‘M’ manufacturing standards (20)

Schedule m
Schedule  m Schedule  m
Schedule m
 
Drugs & Cosmetics Act 1940 Part VI
Drugs & Cosmetics Act 1940 Part VIDrugs & Cosmetics Act 1940 Part VI
Drugs & Cosmetics Act 1940 Part VI
 
SCHEDULE T GMP INDIAN SYSTEM OF MEDICINE
SCHEDULE T GMP INDIAN SYSTEM OF MEDICINE SCHEDULE T GMP INDIAN SYSTEM OF MEDICINE
SCHEDULE T GMP INDIAN SYSTEM OF MEDICINE
 
Mph 02 (shubham)
Mph 02 (shubham)Mph 02 (shubham)
Mph 02 (shubham)
 
Drugs & Cosmetics Act 1940 Part V
Drugs & Cosmetics Act 1940 Part VDrugs & Cosmetics Act 1940 Part V
Drugs & Cosmetics Act 1940 Part V
 
Schedule M-Jurisprudence
Schedule M-JurisprudenceSchedule M-Jurisprudence
Schedule M-Jurisprudence
 
Schedule m iii
Schedule m iiiSchedule m iii
Schedule m iii
 
SCHEDULE M,industrial pharmacy 3rd sem.pptx
SCHEDULE M,industrial pharmacy 3rd sem.pptxSCHEDULE M,industrial pharmacy 3rd sem.pptx
SCHEDULE M,industrial pharmacy 3rd sem.pptx
 
SCHEDULE M, Pharmaceutical Jurisprudence, 5th sem
SCHEDULE M, Pharmaceutical Jurisprudence, 5th semSCHEDULE M, Pharmaceutical Jurisprudence, 5th sem
SCHEDULE M, Pharmaceutical Jurisprudence, 5th sem
 
Manufacturing facility of parentarals as per schedule m
Manufacturing facility of parentarals as per schedule mManufacturing facility of parentarals as per schedule m
Manufacturing facility of parentarals as per schedule m
 
C gmp
C gmpC gmp
C gmp
 
Schedule t
Schedule tSchedule t
Schedule t
 
C gmp final
C gmp finalC gmp final
C gmp final
 
Schedule T Good Manufacturing Practice Indian systems of Medicine
Schedule T Good Manufacturing Practice Indian systems of MedicineSchedule T Good Manufacturing Practice Indian systems of Medicine
Schedule T Good Manufacturing Practice Indian systems of Medicine
 
Schedule M- Drugs and cosmetic act 1940 and rules 1945
Schedule M- Drugs and cosmetic act 1940 and rules 1945Schedule M- Drugs and cosmetic act 1940 and rules 1945
Schedule M- Drugs and cosmetic act 1940 and rules 1945
 
GMP, Goods manufacturer Practices, Drug and Cosmetic act
GMP, Goods manufacturer Practices, Drug and Cosmetic actGMP, Goods manufacturer Practices, Drug and Cosmetic act
GMP, Goods manufacturer Practices, Drug and Cosmetic act
 
GMP presentation.pptx
GMP presentation.pptxGMP presentation.pptx
GMP presentation.pptx
 
Scedule T.pptx
Scedule T.pptxScedule T.pptx
Scedule T.pptx
 
Schedule M drugs and Cosmetics_Good manufacturing practices
Schedule M drugs and Cosmetics_Good manufacturing practicesSchedule M drugs and Cosmetics_Good manufacturing practices
Schedule M drugs and Cosmetics_Good manufacturing practices
 
1.c gmp as per schedule m
1.c gmp as per schedule m 1.c gmp as per schedule m
1.c gmp as per schedule m
 

More from RAHUL PAL

Niosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdfNiosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdfRAHUL PAL
 
Niosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxNiosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxRAHUL PAL
 
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...RAHUL PAL
 
Thakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdfThakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdfRAHUL PAL
 
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...RAHUL PAL
 
Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...RAHUL PAL
 
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...RAHUL PAL
 
Determination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfDetermination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfRAHUL PAL
 
Pharmaceutical Suspension.ppt
Pharmaceutical Suspension.pptPharmaceutical Suspension.ppt
Pharmaceutical Suspension.pptRAHUL PAL
 
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptPHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptRAHUL PAL
 
Partition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptxPartition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptxRAHUL PAL
 
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)RAHUL PAL
 
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...RAHUL PAL
 
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...RAHUL PAL
 
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...RAHUL PAL
 
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...RAHUL PAL
 
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptxRAHUL PAL
 
Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...RAHUL PAL
 
Nucleic Acid Based Therapeutics Delivery.pdf
Nucleic Acid Based Therapeutics Delivery.pdfNucleic Acid Based Therapeutics Delivery.pdf
Nucleic Acid Based Therapeutics Delivery.pdfRAHUL PAL
 
Introduction to Pharmacy.pptx
Introduction to Pharmacy.pptxIntroduction to Pharmacy.pptx
Introduction to Pharmacy.pptxRAHUL PAL
 

More from RAHUL PAL (20)

Niosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdfNiosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdf
 
Niosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxNiosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptx
 
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
 
Thakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdfThakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdf
 
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
 
Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...
 
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
 
Determination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfDetermination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdf
 
Pharmaceutical Suspension.ppt
Pharmaceutical Suspension.pptPharmaceutical Suspension.ppt
Pharmaceutical Suspension.ppt
 
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptPHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
 
Partition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptxPartition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptx
 
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
 
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
 
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
 
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
 
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
 
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
 
Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...
 
Nucleic Acid Based Therapeutics Delivery.pdf
Nucleic Acid Based Therapeutics Delivery.pdfNucleic Acid Based Therapeutics Delivery.pdf
Nucleic Acid Based Therapeutics Delivery.pdf
 
Introduction to Pharmacy.pptx
Introduction to Pharmacy.pptxIntroduction to Pharmacy.pptx
Introduction to Pharmacy.pptx
 

Recently uploaded

How to Manage Buy 3 Get 1 Free in Odoo 17
How to Manage Buy 3 Get 1 Free in Odoo 17How to Manage Buy 3 Get 1 Free in Odoo 17
How to Manage Buy 3 Get 1 Free in Odoo 17Celine George
 
4.11.24 Poverty and Inequality in America.pptx
4.11.24 Poverty and Inequality in America.pptx4.11.24 Poverty and Inequality in America.pptx
4.11.24 Poverty and Inequality in America.pptxmary850239
 
4.9.24 Social Capital and Social Exclusion.pptx
4.9.24 Social Capital and Social Exclusion.pptx4.9.24 Social Capital and Social Exclusion.pptx
4.9.24 Social Capital and Social Exclusion.pptxmary850239
 
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptxDecoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptxDhatriParmar
 
Mythology Quiz-4th April 2024, Quiz Club NITW
Mythology Quiz-4th April 2024, Quiz Club NITWMythology Quiz-4th April 2024, Quiz Club NITW
Mythology Quiz-4th April 2024, Quiz Club NITWQuiz Club NITW
 
4.9.24 School Desegregation in Boston.pptx
4.9.24 School Desegregation in Boston.pptx4.9.24 School Desegregation in Boston.pptx
4.9.24 School Desegregation in Boston.pptxmary850239
 
ICS 2208 Lecture Slide Notes for Topic 6
ICS 2208 Lecture Slide Notes for Topic 6ICS 2208 Lecture Slide Notes for Topic 6
ICS 2208 Lecture Slide Notes for Topic 6Vanessa Camilleri
 
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptxBIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptxSayali Powar
 
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...DhatriParmar
 
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...Association for Project Management
 
MS4 level being good citizen -imperative- (1) (1).pdf
MS4 level   being good citizen -imperative- (1) (1).pdfMS4 level   being good citizen -imperative- (1) (1).pdf
MS4 level being good citizen -imperative- (1) (1).pdfMr Bounab Samir
 
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...Nguyen Thanh Tu Collection
 
Objectives n learning outcoms - MD 20240404.pptx
Objectives n learning outcoms - MD 20240404.pptxObjectives n learning outcoms - MD 20240404.pptx
Objectives n learning outcoms - MD 20240404.pptxMadhavi Dharankar
 
Narcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfNarcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfPrerana Jadhav
 
PART 1 - CHAPTER 1 - CELL THE FUNDAMENTAL UNIT OF LIFE
PART 1 - CHAPTER 1 - CELL THE FUNDAMENTAL UNIT OF LIFEPART 1 - CHAPTER 1 - CELL THE FUNDAMENTAL UNIT OF LIFE
PART 1 - CHAPTER 1 - CELL THE FUNDAMENTAL UNIT OF LIFEMISSRITIMABIOLOGYEXP
 

Recently uploaded (20)

Plagiarism,forms,understand about plagiarism,avoid plagiarism,key significanc...
Plagiarism,forms,understand about plagiarism,avoid plagiarism,key significanc...Plagiarism,forms,understand about plagiarism,avoid plagiarism,key significanc...
Plagiarism,forms,understand about plagiarism,avoid plagiarism,key significanc...
 
How to Manage Buy 3 Get 1 Free in Odoo 17
How to Manage Buy 3 Get 1 Free in Odoo 17How to Manage Buy 3 Get 1 Free in Odoo 17
How to Manage Buy 3 Get 1 Free in Odoo 17
 
4.11.24 Poverty and Inequality in America.pptx
4.11.24 Poverty and Inequality in America.pptx4.11.24 Poverty and Inequality in America.pptx
4.11.24 Poverty and Inequality in America.pptx
 
4.9.24 Social Capital and Social Exclusion.pptx
4.9.24 Social Capital and Social Exclusion.pptx4.9.24 Social Capital and Social Exclusion.pptx
4.9.24 Social Capital and Social Exclusion.pptx
 
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptxDecoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
 
Mythology Quiz-4th April 2024, Quiz Club NITW
Mythology Quiz-4th April 2024, Quiz Club NITWMythology Quiz-4th April 2024, Quiz Club NITW
Mythology Quiz-4th April 2024, Quiz Club NITW
 
4.9.24 School Desegregation in Boston.pptx
4.9.24 School Desegregation in Boston.pptx4.9.24 School Desegregation in Boston.pptx
4.9.24 School Desegregation in Boston.pptx
 
ICS 2208 Lecture Slide Notes for Topic 6
ICS 2208 Lecture Slide Notes for Topic 6ICS 2208 Lecture Slide Notes for Topic 6
ICS 2208 Lecture Slide Notes for Topic 6
 
Spearman's correlation,Formula,Advantages,
Spearman's correlation,Formula,Advantages,Spearman's correlation,Formula,Advantages,
Spearman's correlation,Formula,Advantages,
 
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptxBIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
 
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
 
Paradigm shift in nursing research by RS MEHTA
Paradigm shift in nursing research by RS MEHTAParadigm shift in nursing research by RS MEHTA
Paradigm shift in nursing research by RS MEHTA
 
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
 
MS4 level being good citizen -imperative- (1) (1).pdf
MS4 level   being good citizen -imperative- (1) (1).pdfMS4 level   being good citizen -imperative- (1) (1).pdf
MS4 level being good citizen -imperative- (1) (1).pdf
 
Mattingly "AI & Prompt Design" - Introduction to Machine Learning"
Mattingly "AI & Prompt Design" - Introduction to Machine Learning"Mattingly "AI & Prompt Design" - Introduction to Machine Learning"
Mattingly "AI & Prompt Design" - Introduction to Machine Learning"
 
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
 
Objectives n learning outcoms - MD 20240404.pptx
Objectives n learning outcoms - MD 20240404.pptxObjectives n learning outcoms - MD 20240404.pptx
Objectives n learning outcoms - MD 20240404.pptx
 
Narcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfNarcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdf
 
PART 1 - CHAPTER 1 - CELL THE FUNDAMENTAL UNIT OF LIFE
PART 1 - CHAPTER 1 - CELL THE FUNDAMENTAL UNIT OF LIFEPART 1 - CHAPTER 1 - CELL THE FUNDAMENTAL UNIT OF LIFE
PART 1 - CHAPTER 1 - CELL THE FUNDAMENTAL UNIT OF LIFE
 
CARNAVAL COM MAGIA E EUFORIA _
CARNAVAL COM MAGIA E EUFORIA            _CARNAVAL COM MAGIA E EUFORIA            _
CARNAVAL COM MAGIA E EUFORIA _
 

Schedule ‘M’ manufacturing standards

  • 1. Schedule ‘M’ DETAILED STUDY Rahul Pal B. Pharm (5th Sem)
  • 2. Schedule “M” “Goods Manufacturing Practices (GMP)” are minimum standards used in the manufacturing process that assure that the product meets requirements of safety, identity, strength, quality, and purity.  The FDA attempts to inspect manufacturers every 2 years.  The Schedule M has again been amended in a major way by the Drugs and Cosmetics (8th Amendment) Rules, 2001 w.e.f. 11th December 2001.  These rules shall not apply to the manufacturers who are presently licensed to manufacture drugs for the period up to the 31st Dec. 2003.  The manufacturing premises shall be used exclusively for production of drugs and not for any other manufacturing.
  • 3. • It is defined as “the part of quality assurance which is aimed to ensure that the product is consistently manufactured to the quality appropriate to their intended use”. • It prescribes the requirements of premises, plant and equipment needed for setting up manufacturing unit. Part: 01. Requirements for Premises & Materials: Part: 02. Requirements for Plant & Equipments:  Area.  Equipments. Parts of Schedule “M”:  Part 1.  Part 1A.  Part 1B.  Part 1C.  Part 1D.  Part 1E. 1) Location & surrounding. 2) Buildings & Premises. 3) Water Supply. 4) Disposable of Waste. 5) Storage. 6) Working Space. 7) Sterile Products. 8) Container’s Cleaning. 9) Machinery. 10) Raw materials. 11) Equipments. 12) Batch manufacturing Record. 13) Health Clothing, Sanitation & Hygiene of Workers. 14) Medical Services. 15) Distribution Record. 16) Record of Marketing Complaints. 17) Quality Control.
  • 4. Part-1: Requirements for Premises and Materials 01). Locations and Surroundings*: The factory building shall be situated and constructed to avoid contamination from sewerage, drain, disagreeable, dust and smoke etc. 02). Buildings and Premises*: Manufacturing shall permit work under hygienic conditions. It should be free from any insects. Light and ventilation facility should be adequate. Walls and floor should be free from cracks and damp. It shall be located so as to be: a) The flooring shall be smooth. b) Building should have a proper drainage system. c) Proper fire safety measures and proper exists should be there. • Drying space for raw material, in process medicines should be separate and measures should be done to prevent it from flies/insects/dust etc. 03. Water Supply*: Water supply should be pure and of potable quality. Adequate provision of water for wasting the premises shall be made.
  • 5. 04. Disposable of Waste*: (i) Disposal of sewage and effluents from the factory should be as per “Environment Pollution Control Board’’. (ii) All bio-medical wastes should be destroyed as per “Biomedical Waste management rules-1996”. 05. Stores*: Store should have adequate space for independently and separately store raw material, packaging material and finished products. 06. Working Space*: Manufacturing area should be adequate for orderly placement of equipment, machinery and material used during manufacturing operations and quality control to facilitate easy and safe working. 07. Sterile Products*: Sterile products separate enclosed areas shall be provided with the air lock system for the entry and shall be essentially dust free and has to be carried out. • Air supply shall be filtered through bacteria proof filter (HEPA filter). Access to manufacturing area shall be restricted to minimum number of authorized personal. • Special procedure to be followed for entering and leaving the manufacturing area shall be written down and displayed.
  • 6. 08. Container’s Cleaning*: Washing, cleaning and drying section of containers such as bottles and jars should have adequate arrangement. 09. Machinery*: To carry out manufacturing process, adequate machinery and equipment require. These machineries could be manually operated or semi- automatic or fully automatic based upon your need and investment. 10. Raw-Materials*: The licensee shall keep on inventory of all raw material to be used at any stage of manufacture of drugs and maintain the record as per schedule U. All such raw material be: (a) Identified and their container examined for damage and assigned control number. (b) Stored at optimum temperature and relative humidity. (c) Systematically sampled by quality control personnel. (d) Tested for compliance with required standard of quality. • The stock rotation is so organized that, it is on the basis of first come first out.
  • 7. 11. Equipment*: Equipment used for the manufacturing shall be constructed designed, installed and maintained to: a. Achieve operational efficiency to attain desired quality. b. Minimize any contamination of drug and their container during manufacture. • Equipment used for critical steps in progress shall be maintained by device capable of recording the parameter or withdrawn systems to indicate malfunction. 12. Batch Manufacturing Record*: Batch record should be maintained irrespective of product manufactured: • Manufacturing records are required to provide the list of raw materials and their quantities obtained from the store, tests conducted during the various stages of manufacture like taste, colour, physical characteristics and chemical tests.  Manufacturing Batch record should be signed by production chemist and analytical chemist. • Only after the manufactured drugs have been verified and accepted quality shall be allowed to be cleared for sale.
  • 8. 13. Health Clothing, Sanitation and Hygiene of Workers*: All workers should be healthy and should be free from contagious diseases.  Proper uniform should be provided to workers according to nature of work.  A uniform may include cloth or synthetic covering for hands, feet and head wherever required.  Adequate facilities for personal use provided like clean towel, soap etc.  Lavatories for men and women should be separate and should be away from processing and manufacturing area. • Changing room facility should also be provided for changing their clothes. 14. Medical Services*: Adequate facility for first aids should be provided by manufacturer. Medical examination of workers at the time of employment and periodical check-up should be conducted at least once in a year and proper record should be maintained.
  • 9. 15. Distribution Record*: Distribution record (Dispatch register) should be maintained to facilitate process of prompt and complete recall of the batch. Distribution record should be maintained till expiry of batch. 16. Record of Market Complaints*: A register should maintain to record all reports of market complaints received regarding the products sold in the market. • The manufacturer shall enter all data received on such market complaints; investigations carried out by the manufacturers regarding the complaint & shall also be recorded. • “Once in a period of six months the manufacturer shall submit the record of such complaints to the licensing authority.” • Reports of any adverse reaction resulting from the use of drugs maintained in a separate register by manufacturer. 17. Quality Control*: A manufacturer can set-up own quality control section or testing could be done through government approved testing laboratory.
  • 10. Part-2: Requirements for Plant and Equipments 01. Area: a) Basic Installation - Requires minimum of 30 sq. mt. (for tablets manufacturing, up to 60 sq. mt.) b) Ancillary Area: 10 sq. mt. (for tablets manufacturing, up to 20 sq. mt.) 02. Equipment: Colloidal mill, mixing and storage tanks, stainless steel containers, Planetary mixer, Triple roller, tube filling equipments, filter proof cap sealing machine, water distillation unit, clarity testing inspection unit, disintegrator and sifter, granulator, tray or fluidized bed driers, weighing machine, tablet compression machine, tablet inspection unit, dissolution test apparatus, hardness tester, friability tester, disintegration test apparatus, air conditioners, polishing pan, jacketed kettle, leakage test apparatus, capsule filling unit, hot air ovens, Laminar air flow unit, bottle washing machines, autoclave, transfer pumps, trimming machine, cutting machine etc.
  • 11. Parts of Schedule ‘M’ • Part 1: Describes Good Manufacturing Practices for Premises and Material. • Part 1A: Describes the specific requirement for manufacture of sterile products. Parenteral preparations and Sterile Ophthalmic Preparations. • Part 1B: Describes the specific requirements for manufacture of oral solid forms (Capsule and Tablets) • Part 1C: Describes the specific requirements for manufacture of oral liquids (syrups, elixirs, emulsions and suspensions). • Part 1D: Describes the specific requirements for manufacture of topical products i.e. External Preparations (Cream, Ointments, Pastes, Emulsions, Lotions, Solutions) • Part 1E: Describes the specific requirements for manufacture of Metered Dose Inhalers (MDI). The other associated codes such as those of Good laboratory practice (GLP) and Good clinical practice (GCP).